Calcitonin gene‐related peptide (CGRP) is a potent non‐endothelium‐dependent inhibitor of coronary vasomotor tone

Barry Greenberg,K. Rhoden,P. Barnes
DOI: https://doi.org/10.1111/j.1476-5381.1987.tb11382.x
IF: 7.3
1987-12-01
British Journal of Pharmacology
Abstract:1 Ring segments of bovine left circumflex coronary artery were pre‐contracted with 5‐hydroxytryptamine or phenylephrine and then exposed to increasing concentrations of calcitonin gene‐related peptide (CGRP) and other drugs. 2 CGRP administration resulted in dose‐dependent inhibition of induced tone. Maximal relaxation to CGRP was 89 ± 5% and the concentration required to achieve 50% maximal relaxation (EC50) was 2.11 ± 1.35 × 10−9 m. 3 CGRP‐induced relaxation was not affected by removal of endothelial cells nor was it significantly altered by incubation of coronary vessels with atropine, propranolol, phentolamine (all 10−6 m) or indomethacin (10−5 m). 4 From these data we conclude that CGRP is a potent inhibitor of coronary artery vasomotor tone which appears to act directly on vascular smooth muscle rather than through the release of a secondary mediator. These data support the possibility that CGRP may play a role in non‐adrenergic, non‐cholinergic regulation of coronary artery tone.
What problem does this paper attempt to address?